- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Gabapentin Linked to Atrial Fibrillation in Young Patient: Case Report
![Gabapentin Linked to Atrial Fibrillation in Young Patient: Case Report Gabapentin Linked to Atrial Fibrillation in Young Patient: Case Report](https://medicaldialogues.in/h-upload/2021/01/04/750x450_145317-gabapentin.webp)
Gabapentin, a widely prescribed medication for neuropathic pain and seizure disorders, has recently come under scrutiny due to its potential impact on the cardiovascular system. While its primary side effects are associated with the central nervous system, emerging evidence suggests a link between gabapentin and an increased risk of atrial fibrillation, particularly among elderly patients with preexisting heart conditions.
In a recent case study, a young African American male in his twenties presented at a chronic pain clinic with lumbar radiculitis, a condition causing pain along the lower back and legs. Four days after initiation of gabapentin treatment, an unexpected and alarming development occurred - the patient was diagnosed with atrial fibrillation, a condition characterized by irregular and often rapid heartbeats.
Laboratory tests conducted on the patient revealed no significant abnormalities, including normal blood counts, comprehensive metabolic panel, toxicology screen, and thyroid-stimulating hormone levels. However, transthoracic and transesophageal echocardiography unveiled a patent foramen ovale, a small hole in the heart that had gone undetected, along with a right-to-left shunt, which can potentially allow blood clots to bypass the lungs and travel to other parts of the body.
Medical intervention was promptly initiated, involving heart rate control using diltiazem and blood thinning medication apixaban. Within 24 hours of admission, direct current cardioversion was performed, successfully restoring the patient's heart rhythm to normal. Following the procedure, the patient was discharged with a regimen of diltiazem and apixaban. Notably, after one month, the patient's medication was adjusted, transitioning from apixaban to low-dose aspirin.
This case study raises concerns about the potential association between gabapentin and atrial fibrillation, even in young and otherwise healthy individuals. While the majority of existing evidence focuses on elderly patients with existing cardiac conditions, this instance highlights the need for heightened awareness and monitoring across a broader demographic.
As the use of gabapentin continues to rise as a substitute for opioids in managing pain, medical professionals and patients alike must remain vigilant about potential side effects, including those affecting the cardiovascular system.
Source:
Park, S. H., Hunter, K., Berry, H., & Martins, Y. C. (2023). Atrial fibrillation induced by gabapentin: a case report. In Journal of Medical Case Reports (Vol. 17, Issue 1). Springer Science and Business Media LLC. https://doi.org/10.1186/s13256-023-03975-1
Neuroscience Masters graduate
Jacinthlyn Sylvia, a Neuroscience Master's graduate from Chennai has worked extensively in deciphering the neurobiology of cognition and motor control in aging. She also has spread-out exposure to Neurosurgery from her Bachelor’s. She is currently involved in active Neuro-Oncology research. She is an upcoming neuroscientist with a fiery passion for writing. Her news cover at Medical Dialogues feature recent discoveries and updates from the healthcare and biomedical research fields. She can be reached at editorial@medicaldialogues.in
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: editorial@medicaldialogues.in. Contact no. 011-43720751